The store will not work correctly when cookies are disabled.
4-(cyclooctanecarboxamido)phenyl 4-methylbenzenesulfonate
ID: ALA4476410
PubChem CID: 155538337
Max Phase: Preclinical
Molecular Formula: C22H27NO4S
Molecular Weight: 401.53
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(S(=O)(=O)Oc2ccc(NC(=O)C3CCCCCCC3)cc2)cc1
Standard InChI: InChI=1S/C22H27NO4S/c1-17-9-15-21(16-10-17)28(25,26)27-20-13-11-19(12-14-20)23-22(24)18-7-5-3-2-4-6-8-18/h9-16,18H,2-8H2,1H3,(H,23,24)
Standard InChI Key: XYOGJCLXOKQTNI-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
32.3533 -25.0853 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.7661 -25.7952 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
33.1745 -25.0828 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.1844 -24.9779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1833 -25.7975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8913 -26.2065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6010 -25.7970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5981 -24.9744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8895 -24.5691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.3043 -24.5631 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.0136 -24.9690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7197 -24.5578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0166 -25.7862 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.4752 -26.2055 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.0598 -26.2044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3531 -25.7952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6473 -26.2037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6481 -27.0209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3606 -27.4277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0635 -27.0168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6770 -23.7064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6921 -24.5256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1265 -25.1126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0898 -23.1407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2707 -23.1559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7050 -23.7429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3072 -25.1279 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9416 -27.4315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
8 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
5 14 1 0
14 2 1 0
2 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
21 22 1 0
22 23 1 0
21 24 1 0
24 25 1 0
25 26 1 0
26 12 1 0
12 27 1 0
27 23 1 0
18 28 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 401.53 | Molecular Weight (Monoisotopic): 401.1661 | AlogP: 5.06 | #Rotatable Bonds: 5 |
Polar Surface Area: 72.47 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 5.94 | CX LogD: 5.94 |
Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.71 | Np Likeness Score: -1.21 |
References
1. Semreen MH, El-Gamal MI, Ullah S, Jalil S, Zaib S, Anbar HS, Lecka J, Sévigny J, Iqbal J.. (2019) Synthesis, biological evaluation, and molecular docking study of sulfonate derivatives as nucleotide pyrophosphatase/phosphodiesterase (NPP) inhibitors., 27 (13): [PMID:31088715] [10.1016/j.bmc.2019.04.031] |